Project Grant R01HL174863

Award Date 8/1/25
Completion Date 5/31/30
Dollars Obligated $771K
Federal Grant Program
93.837
Assistance Type
Project Grant
Place of Performance
New York, NY 10032, USA
Similar Awards
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $129,612 to Case Western Reserve University (CWRU) to develop new AI-based methods for evaluating high-risk coronary atherosclerotic plaque using non-invasive coronary CT angiography (CCTA) imaging. The research aims to compare CCTA image features to high-resolution intravascular optical coherence tomography (IVOCT) imaging, considered...
This National Science Foundation (NSF) Engineering program (CFDA 47.041) project grant award of $650,000 to The Trustees of Columbia University in the City of New York will support research to advance understanding of the blood-clot interactions that may result in stroke for patients with heart rhythm disorders like atrial fibrillation. The research aims to create a computational model of the left atrium to investigate how the heart's structure changes blood flow patterns, elevating the risk...
The National Heart Lung and Blood Institute (NHLBI) awarded a $810,650 Project Grant (CFDA 93.837 Cardiovascular Diseases Research) to Cedars-Sinai Medical Center. The funding will support the development and validation of an artificial intelligence (AI)-enabled algorithm to characterize fibrotic and calcific aortic valve tissue from computed tomography angiography (CTA) scans. The goal is to predict rapid aortic valve disease progression and create an AI-powered risk score to predict...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) provides $829,103 to The Trustees of Columbia University in the City of New York to conduct research on functional coagulation and hemostasis after intracerebral hemorrhage (ICH). The goal is to perform a multimodal assessment of coagulation in ICH patients using traditional clinical assays, contemporary whole blood viscoelastic hemostatic assays,...
This federal Project Grant award, totaling $753,813 and provided by the National Heart Lung and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research), supports research to develop novel machine learning techniques for predicting cardiovascular outcomes in patients with clonal hematopoiesis of indeterminate potential (CHIP). The key goals are to use cardiac MRI imaging and genomic data to: 1) Develop a machine learning model to accurately identify CHIP patients and predict their risk...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $299,604 to Case Western Reserve University to develop and validate a novel transfer volume regression model. This model aims to enable quantitative clinical risk predictions for major cardiovascular events, including stroke, heart attack, heart failure, and death. The project will leverage commonly used, low-cost screening programs to...
This Project Grant from the National Heart, Lung and Blood Institute, part of the Department of Health and Human Services, provides $920,176 under the Cardiovascular Diseases Research program to develop a smart aspiration catheter with fiber optic pressure sensors for mechanical thrombectomy procedures to treat acute ischemic stroke. The catheter will be designed, prototyped and validated at Worcester Polytechnic Institute to provide real-time data to interventionalists on the interaction...
The National Heart, Lung, and Blood Institute (NHLBI) has awarded a Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837) to The Trustees of Columbia University in the City of New York. The $688,291 grant will fund the development and clinical validation of a novel 3D ultrasound technique called Electromechanical Wave Imaging (EWI) for non-invasive, personalized cardiac arrhythmia mapping. Over a 5-year period ending in June 2029, the project aims to demonstrate that...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), is focused on leveraging deep learning to link normal variation in aortic valve hemodynamics to the pathogenesis of aortic stenosis. The $722,299 award to The Regents of the University of California, San Francisco (UCSF), with a period of performance from August 1, 2025 to July 31, 2030, will enable UCSF to measure aortic valve...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $742,395 to Case Western Reserve University (CWRU) to develop and validate a machine learning-based analysis of coronary artery calcium scans (CTCS) to identify biomarkers for predicting heart failure risk. The 4-year project aims to create an automated tool for extracting CTCS-derived radiomics, develop a comprehensive heart failure risk...

This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), is focused on enabling clinicians to better leverage information from carotid computed tomographic angiography (CTA) scans to assess stroke risk. The $771,485 award, effective August 1, 2025 through May 31, 2030, aims to: 1) identify reliable imaging-derived carotid plaque features associated with cryptogenic stroke, 2) develop an advanced computer vision algorithm to evaluate carotid CTA images, and 3) evaluate the algorithm's ability to predict recurrent stroke events in a prospective study. The awardee, The Trustees of Columbia University in the City of New York, will leverage its extensive expertise in carotid disease and cryptogenic stroke research to deliver this project. If successful, this work will provide clinicians with a tool to better utilize carotid CTA data to reduce the burden of vascular disease caused by atherosclerosis.

Generated 8/5/25, 4:16 AM